The Prospectus Supplement, the Base Shelf Prospectus, and any amendment, as applicable, and a related corporate presentation are accessible under the Company’s profile on SEDAR+ at www.sedarplus.ca ...

Abivax receives a "Strong Buy" rating, driven by positive phase 3 ABTECT induction data for obefazimod in moderate-to-severe ...

Emerging Growth Conference 88 December 11, 2025 9:05 AM ESTCompany ParticipantsJean-Marie Clouet - Vice President ...

Q2 Metals will host a live year-end webcast presentation on Thursday, December 18 at 08:00 AM PST (11:00 AM EST). Management will review the Company’s 2025 performance, highlight upcoming catalysts, ...

On December 10, 2025, FitLife Brands, Inc. introduced a new corporate presentation for business purposes. This move is part of their strategy to enhance communication and engagement with stakeholders, ...

Oral presentation from pooled analyses of the IMerge population suggests that treatment-emergent cytopenias may reflect on-target effects associated with meaningful clinical outcomes, including hemogl ...

IBI3003 is a novel trispecific antibody targeting GPRC5D, BCMA and CD3 simultaneously. Its dual-targeting design against BCMA and GPRC5 aims to overcome single antigen escape in multiple myeloma (MM).

Detailed price information for Assembly Biosciences (ASMB-Q) from The Globe and Mail including charting and trades.